SLC35A2 and gastric adenocarcinoma: Interestingly, our results revealed the highly up-regulated SLC35A2 expression in STAD tissues with TP53 mutation compared to those without TP53 mutation, which suggests that SLC35A2 may be involved in the carcinogenesis process of the TP53 pathway.